Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Overview

Información sobre este estudio

The purpose of this study is to evaluate the continued safety and probable benefit of the MID-C system for 5 years post-implantation in Adolescent Idiopathic Scoliosis (AIS).

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Adolescent Idiopathic Scoliosis classified as Lenke Type 1 or Type 5 curves.
  • Cobb angle between 40-60 degrees (inclusive).
  • Flexible curve that that reduces to ≤ 30 degrees on lateral side bending radiographs or as evident by traction x-ray.
  • Kyphosis angles of ≤ 55 degrees measured from T5 to T12.
  • Appropriate candidate for posterior surgical approach.
  • Patient has good general health.
  • Patient has no known hypersensitivity or allergies to titanium.
  • Patient’s guardian signs a written informed consent form (ICF).

Exclusion Criteria:

  • Any type of non-idiopathic scoliosis.
  • Any main thoracic deformity that includes vertebral levels and cranial including to T2.
  • Known history of existing malignancy, or any systemic or local infection.
  • Spinal cord abnormalities that require treatment.
  • Known neurological deficit (defined as motor grade < 5/5).
  • Known poor bone quality defined as T score -1.5 or less.
  • For female patient, pregnancy.
  • Previous spine surgery.
  • Active systemic disease, such as AIDS, HIV, or active infection.
  • Active infection or the skin is compromised at the surgical site.
  • Systemic disease that would affect the Patient’s welfare or overall outcome of the study.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Annalise Larson, M.D.

Abierto para la inscripción

Contact information:

Smitha Mathew M.B.B.S.

(507) 538-3560

Mathew.Smitha@mayo.edu

Minneapolis, Minn.

Investigador principal de Mayo Clinic

Annalise Larson, M.D.

Abierto para la inscripción

Contact information:

Smitha Mathew M.B.B.S.

(507) 538-3560

Mathew.Smitha@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20490428

Mayo Clinic Footer